AMY WEST: Open Payments
NPI 1548246903 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 80 payments from 18 companies in 2025. Trend: 2023 $1,072 · 2024 $1,575 · 2025 $1,508
Food & beverage: $1,443Education: $65
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $238 |
| Arcutis Biotherapeutics, Inc. | 22 | $222 |
| Janssen Biotech, Inc. | 8 | $198 |
| Regeneron Healthcare Solutions, Inc. | 6 | $182 |
| GENZYME CORPORATION | 4 | $112 |
| ABBVIE INC. | 3 | $79 |
| LEO Pharma Inc. | 3 | $75 |
| PFIZER INC. | 4 | $73 |
| Organon LLC | 5 | $55 |
| Galderma Laboratories, L.P. | 2 | $50 |
Products named: DUPIXENT, Bimzelx, Zoryve, TREMFYA, CIBINQO, RINVOQ, VTAMA, ADBRY.
Industry payments across AZ — which companies pay providers there.
